LA JOLLA PHARMACEUTICAL CO (14)

Browse by Contract Category

Contracts

Description of Securities (Filed With SEC on March 9, 2022)
Amended Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards (Filed With SEC on November 4, 2021)
License Agreement, dated as of August 3, 2006, by and between the Registrant and the President and Fellows of Harvard College, as amended (Filed With SEC on March 8, 2021)
Contingent Value Rights Agreement, dated as of July 17, 2020, between La Jolla Pharmaceutical Company and American Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on July 29, 2020)
Agreement and Plan of Merger by and among the La Jolla, Merger Sub and Tetraphase, dated June 24, 2020 (Filed With SEC on June 24, 2020)
Form of Indemnification Agreement (Filed With SEC on March 2, 2020)
PAION AG Exclusive Licensing Agreement, dated January 12, 2021 (Filed With SEC on March 8, 2021)
Amendment, dated as of December 5, 2017, by and between the Registrant and the President and Fellows of Harvard College, as amended (Filed With SEC on March 8, 2021)
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards dated as of July 28, 2020 (Filed With SEC on November 9, 2020)
Form of Contingent Value Rights Agreement, by and between La Jolla and the Rights Agent (Filed With SEC on June 24, 2020)
Form of Support Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the stockholder named therein (Filed With SEC on June 24, 2020)
Form of Exchange Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the holder named therein (Filed With SEC on June 24, 2020)
Description of Securities (Filed With SEC on March 2, 2020)
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Darryl Wellinghoff dated as of February 25, 2019 (Filed With SEC on March 2, 2020)